Navigation Links
Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
Date:11/28/2007

SOUTH SAN FRANCISCO, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) announced today that it will hold its Third Annual R&D Day on Wednesday, December 5, 2007 from 10:00 a.m. ET / 7:00 a.m. PT to 2:00 p.m. ET / 11:00 a.m. PT in New York. The company will discuss updates to its development pipeline, its collaborations, including those with GSK, BMS and Genentech, and its financial outlook for 2007.

Speakers:

-- George Scangos, PhD, President & Chief Executive Officer of Exelixis,

Inc.

-- Michael Morrissey, PhD, President of Research & Development of

Exelixis, Inc.

-- Frank Karbe, Executive Vice President & Chief Financial Officer of

Exelixis, Inc.

-- Peter Lamb, PhD, Senior Vice President, Discovery Research & Chief

Scientific Officer of Exelixis, Inc.

-- Gisela Schwab, MD, Senior Vice President and Chief Medical Officer of

Exelixis, Inc.

-- Steven Sherman, MD of MD Anderson Cancer Center

-- Vince Miller, MD of Memorial Sloan-Kettering Cancer Center

The event will be webcast and may be accessed in the Event Calendar page under Investors at http://www.exelixis.com.

An archive of this webcast will be available until 9:00 p.m. PT/12:00 a.m. ET on January 4, 2008. Access numbers for this replay are: 1-888-286-8010 (domestic) and 1-617-801-6888 (international); the replay passcode number is: 21270665.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
2. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
3. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
4. Exelixis Announces Closing of Public Offering of Common Stock
5. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
6. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
7. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
8. Exelixis Sells 80% Stake in Artemis to Taconic
9. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
10. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
11. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...HOUSTON, Nov. 24 IES (Na...trical and communications systems and services for...s, announced today that its commercial business gr...con JV to install the electrical systems for the L... at the U.S. Army Medical Research Institute of In...
(Date:11/24/2009)... The New York investment bank KTA Capital... agreed an AU$6.7 mil convertible note private pla...vate placement was arranged by KTA Capital as Neur... New York (PRWEB) November 23,...KTA Capital, LLC ("KTA Capital") has ann...
(Date:11/24/2009)...ARY and BLENHEIM, Ontario, Nov. 24 /PRNewswire-Fir... it is acquiring the assets of Hyland Seeds, a div...he addition of Hyland Seeds will further expand Do...any anticipates the introduction of SmartStax(TM)...ant Trait Technology in corn in 2012. The transact...
(Date:11/24/2009)...T. LOUIS, Nov. 24 Sigma-...nting at the NASDAQ OMX conference on Tuesday, Dec.... Interested parties may listen via live audio bro...e s tor.sig m a a ldrich.com/ . Users can ..., About Sigma-Aldrich: Sigma-Aldrich is a le...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...ounced,today that it has been awarded a $12.9 mill...and Infectious Diseases (NIAID), a part of the US,...ense research in the area,of infectious disease bi...r a five-year period, Caprion,will act as one of t...s,Disease & Biodefense, and will employ its distin...
...09 for $5,000 each, MOUNTAIN VIEW, Calif., Oct. 6... genome sequencing company, today announced its,fo...-scale human genome,sequencing services., The com...n operating in,"stealth mode" from a 32,000-square...o and a half years, Complete Genomics has been rei...
...ment resulting from years of, study by leading r..., Del-Immune V, BOUL...at,the EUPROBIO 2008 Conference, an abstract entit...nduction and its impact on cytotoxicity of,natural...searchers and,educators. Attendees to the presenta...
Other Biology Technology:Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract 2Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequencing Company 2Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequencing Company 3Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequencing Company 4EUPROBIO 2008 Presentation to Highlight Latest Immune Research 2
(Date:11/26/2009)...nt Staphylococcus Aureus ) and other drug-resista...ture plasma prototype devices have been developed ...dal cocktails. , Two prototype devices have been...thy skin (e.g. hands and feet) in hospitals and pu...t; and another to shoot bacteria-killing agents in...
(Date:11/25/2009)...ters, police officers and ambulance workers faced ...er complex. They battled to save people from the c...kled fires and evacuated as many people as they co... people. And making their jobs even harder was the...s and their relatives jammed mobile networks with ...
(Date:11/25/2009)... assistant professors recently received funding fr...ue research beneficial to understanding the enviro...opher Blackwood, assistant professor in the Depart... support two separate research projects. , His f... Communities and Functions from the Leaf to the La...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Hologic to Release Third Quarter Fiscal 2009 Operating Results on Monday August 3 2009 51476 1Hologic to Release Third Quarter Fiscal 2009 Operating Results on Monday August 3 2009 51476 2Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 1Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 2Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 3Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 4Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 5Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 6Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 7Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 8Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 9Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 10Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51468 1Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51468 2Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51468 3
...ntists at the University of Liverpool have found h... spread of cancer cells. , Researchers discovered ...eld around cancer cells and prevents them from cau...tein that exists in the blood. , In diseases su... cells lose growth control and eventually form tum...
...n bone marrow has been used to create early-stage ...forward that will help researchers understand more...h published today (Friday, April 13 2007), in the ... carried out in Germany* by a team of scientists l...iversity of Göttingen but now of the North-east En...
...to growers are likely to soon be able to cultivate...ides against grey mould (Botrytis cinerea). This i...chard Finkers from Wageningen University, with whi... Finkers designed highly efficient methods whereby...The leading company De Ruiter Seeds is already app...
Other Biology News:Scientists discover how body fights to control spread of cancer 2Early-stage sperm cells created from human bone marrow 2Research on grey mould offers possible breakthrough in tomato cultivation 2
Single Pass DNA Sequencing from Agencourt Bioscience
...naround sequencing of individual research samples,...lasmids. Agencourt's world-class, high performance...ed20 bases per day. The key benefits of Agencourt...e 24 48 hour sample turnaround, industry leading ...
Full-Length "Primer Walk" Sequencing from Seqwright
Goat Anti-Wnt2 Polyclonal Antibody, Unconjugated from MBL International
Biology Products: